Literature DB >> 29722070

Simplified and robust one-step radiosynthesis of [18 F]DCFPyL via direct radiofluorination and cartridge-based purification.

Mark H Dornan1,2, José-Mathieu Simard1, Antoine Leblond1,2, Daniel Juneau1,2, Guila Delouya1,2, Fred Saad1,3, Cynthia Ménard1,2, Jean N DaSilva1,2.   

Abstract

[18 F]DCFPyL is a clinical-stage PET radiotracer used to image prostate cancer. This report details the efficient production of [18 F]DCFPyL using single-step direct radiofluorination, without the use of carboxylic acid-protecting groups. Radiolabeling reaction optimization studies revealed an inverse correlation between the amount of precursor used and the radiochemical yield. This simplified approach enabled automated preparation of [18 F]DCFPyL within 28 minutes using HPLC purification (26% ± 6%, at EOS, n = 4), which was then scaled up for large-batch production to generate 1.46 ± 0.23 Ci of [18 F]DCFPyL at EOS (n = 7) in high molar activity (37 933 ± 4158 mCi/μmol, 1403 ± 153 GBq/μmol, at EOS, n = 7). Further, this work enabled the development of [18 F]DCFPyL production in 21 minutes using an easy cartridge-based purification (25% ± 9% radiochemical yield, at EOS, n = 3).
Copyright © 2018 John Wiley & Sons, Ltd.

Entities:  

Keywords:  HPLC-free purification; PET imaging of prostate cancer; automated production; prostate-specific membrane antigen (PSMA) ligand; protection-free radiolabeling

Year:  2018        PMID: 29722070     DOI: 10.1002/jlcr.3632

Source DB:  PubMed          Journal:  J Labelled Comp Radiopharm        ISSN: 0362-4803            Impact factor:   1.921


  5 in total

1.  Site-Specific and Residualizing Linker for 18F Labeling with Enhanced Renal Clearance: Application to an Anti-HER2 Single-Domain Antibody Fragment.

Authors:  Zhengyuan Zhou; Rebecca Meshaw; Michael R Zalutsky; Ganesan Vaidyanathan
Journal:  J Nucl Med       Date:  2021-02-26       Impact factor: 11.082

2.  Automated synthesis of [18F]Ga-rhPSMA-7/ -7.3: results, quality control and experience from more than 200 routine productions.

Authors:  Alexander Wurzer; Daniel Di Carlo; Michael Herz; Antonia Richter; Stephanie Robu; Ralf Schirrmacher; Alba Mascarin; Wolfgang Weber; Matthias Eiber; Markus Schwaiger; Hans-Juergen Wester
Journal:  EJNMMI Radiopharm Chem       Date:  2021-01-23

3.  A new automated and putatively versatile synthesis of the PSMA-ligand derivative [18F]DCFPyL using the FASTlabTM synthesizer.

Authors:  Raphaël Hoareau; Tore Bach-Gansmo; Paul Cumming; Dag Erlend Olberg
Journal:  EJNMMI Radiopharm Chem       Date:  2022-05-04

4.  Image-guided Raman spectroscopy navigation system to improve transperineal prostate cancer detection. Part 2: in-vivo tumor-targeting using a classification model combining spectral and MRI-radiomics features.

Authors:  David Orlando Grajales Lopera; Fabien Picot; Roozbeh Shams; Frédérick Dallaire; Guillaume Sheehy; Stephanie Alley; Maroie Barkati; Guila Delouya; Jean-Francois Carrier; Mirela Birlea; Dominique Trudel; Frédéric Leblond; Cynthia Ménard; Samuel Kadoury
Journal:  J Biomed Opt       Date:  2022-09       Impact factor: 3.758

5.  Radiohybrid Ligands: A Novel Tracer Concept Exemplified by 18F- or 68Ga-Labeled rhPSMA Inhibitors.

Authors:  Alexander Wurzer; Daniel Di Carlo; Alexander Schmidt; Roswitha Beck; Matthias Eiber; Markus Schwaiger; Hans-Jürgen Wester
Journal:  J Nucl Med       Date:  2019-12-20       Impact factor: 10.057

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.